[Current news about epidemiology of syncytial respiratory virus infection].

At present, syncytial respiratory virus is the major agent of respiratory infections in pediatric patients. It can determine an important respiratory distress in particular children, as prematures with an gestational age <32 weeks, children affected by congenital heart diseases or bronchopneumonia dysplasia. In these patients, the prophylaxis with palivizumab is very important to prevent chronic pulmonary diseases.